Ashraf Elghandour
Alexandria, ALX, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion.
Journal: Leukemia & lymphoma
Published: March 17, 2026
Acute Myeloid Leukemia in a Patient With Xeroderma Pigmentosum: A Case Report.
Journal: Clinical case reports
Published: January 30, 2026
Burden of Disease, Treatment Patterns, and Healthcare Resource Utilization in Multiple Myeloma in the Middle East and North Africa Region: A Targeted Literature Review.
Journal: Oncology and therapy
Published: December 01, 2025
Unraveling Histiocytic Disorders: Two Cases From Resource-Limited Settings.
Journal: Cureus
Published: December 30, 2024
The Fusion Genes and Their Relation with Genetic Variants in Egyptian AML Patients.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: November 24, 2024
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE.
Journal: Blood advances
Published: June 13, 2022
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.
Journal: British journal of haematology
Published: March 21, 2017
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial.
Journal: The Lancet. Haematology
Published: July 15, 2016
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
Journal: The Lancet. Oncology
Published: September 23, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026